RVMD in the 13F filings
Revolution Medicines Inc · CUSIP 76155X100
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 8 May 2026
- Managers listing it
- 34
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 17 listed it in both
- Shares listed
- 51,679,253
- combined, among listed positions
- Reported value
- $5.0bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 20 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -6,857,024.
Managers listing RVMD in Q1 2026
34 of 34 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Investments LPexisting position · 1,558,807 shares now+1,137,072
- Holocene Advisors LPexisting position · 2,468,644 shares now+560,696
- Man Group PLCexisting position · 275,270 shares now+177,765
- Squarepoint Ops LLCexisting position · 120,769 shares now+97,134
- Voloridge Investment Management LLCexisting position · 368,325 shares now+46,036
Reductions
- Janus Henderson Group Ltdexisting position · 9,766,496 shares now-2,537,006
- Jane Street Group LLCexisting position · 33,603 shares now-1,056,813
- Farallon Capital Management LLCexisting position · 13,604,796 shares now-978,000
- Wellington Management Group LLPexisting position · 6,027,819 shares now-959,820
- Citadel Advisors LLCexisting position · 400,053 shares now-902,308
New positions and exits
New (6)
Exited (1)
- Point72 Asset Management LPwas $36m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2020 | 4 | $21m | n.a. | n.a. |
| Q2 2020 | 1 | $29m | n.a. | n.a. |
| Q3 2020 | 3 | $388m | n.a. | n.a. |
| Q4 2020 | 4 | $451m | n.a. | n.a. |
| Q1 2021 | 5 | $846m | n.a. | n.a. |
| Q2 2021 | 5 | $325m | n.a. | n.a. |
| Q3 2021 | 3 | $133m | n.a. | n.a. |
| Q4 2021 | 3 | $174m | n.a. | n.a. |
| Q1 2022 | 3 | $174m | n.a. | n.a. |
| Q2 2022 | 3 | $189m | n.a. | n.a. |
| Q3 2022 | 3 | $206m | n.a. | n.a. |
| Q4 2022 | 3 | $263m | n.a. | n.a. |
| Q1 2023 | 5 | $526m | n.a. | n.a. |
| Q2 2023 | 7 | $685m | n.a. | n.a. |
| Q3 2023 | 8 | $766m | n.a. | n.a. |
| Q4 2023 | 8 | $1.0bn | 5 | 3 |
| Q1 2024 | 10 | $1.3bn | 7 | 2 |
| Q2 2024 | 9 | $1.6bn | 4 | 4 |
| Q3 2024 | 10 | $1.9bn | 6 | 3 |
| Q4 2024 | 11 | $2.2bn | 8 | 2 |
| Q1 2025 | 7 | $1.7bn | 5 | 1 |
| Q2 2025 | 8 | $1.7bn | 3 | 4 |
| Q3 2025 | 7 | $2.2bn | 3 | 3 |
| Q4 2025 | 18 | $4.3bn | 23 | 9 |
| Q1 2026 | 15 | $4.8bn | 14 | 20 |
| Q2 2026 | 17 | $10.3bn | 16 | 23 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RVMD and GILD →RVMD and AMGN →RVMD and ARGX →Choose a stock to compare with RVMD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RVMD, latest filings →Back to the 13F Explorer →